Hemostasis and clotting factors: what are they and how are they impacted by hemophilia?
Learn more about blood clotting factors in hemophilia A and B, including where Factor VIII and IX are produced, and the different stages of the clotting cascade.

When you get injured and start bleeding, your body uses a process called hemostasis to help the blood clot, a complex chain reaction where each step triggers the next. The term "hemostasis" comes from "hem-," which means "blood," and "-stasis," which means "to stop."
There are 3 main stages of blood clotting: blood vessel response, platelet plug formation, and the clotting cascade, which lead to the formation of the final clot.
Hemostasis step 1: Blood vessel response
When you experience a bleed, your blood vessels respond by narrowing (a process called vasoconstriction). Like squeezing a garden hose to reduce water flow, your blood vessels tighten to slow down blood loss.
This response can begin within seconds and is controlled by signals from damaged tissue and your nervous system.
Hemostasis step 2: Platelet plug formation
(or "primary hemostasis")
The next step of hemostasis involves platelets. Platelets are tiny cells in your blood that act like first responders when you get a cut or injury. As soon as the platelets receive a signal that a blood vessel has been damaged, they become activated and rush to the site, change shape, and become sticky.
Platelets clump together to form a temporary soft plug that helps stop the bleeding while your body works on a more permanent repair. They also release chemical signals that attract more platelets to the area and strengthen the plug further. This process is also known as "primary hemostasis."
Hemostasis step 3: The clotting cascade
(or "secondary hemostasis")
The final step is the clotting cascade, in which your body creates a strong, stable clot from the soft platelet plug.
Your blood contains proteins called clotting factors. These work together in a chain reaction, helping to form strong fibers that weave through the platelet plug to reinforce it.
This transforms the loose platelet plug into a solid, durable clot that can effectively seal the wound until healing is complete. The clotting cascade is also known as "secondary hemostasis."
The clotting cascade consists of 3 pathways—the extrinsic, intrinsic, and common pathways—that interact to form a stable blood clot.
The extrinsic, intrinsic, and common
pathways of the clotting cascade
The extrinsic pathway is your body's response system at the site of injury. When you get a cut, cells in the damaged tissue release a protein called tissue factor, which combines with blood proteins to begin forming a clot and stop the bleeding.
The intrinsic pathway is your body's slower but longer-lasting clotting system that works inside your blood vessels. When blood vessels are damaged, a series of proteins work together like a chain reaction to help form and maintain stable clots.
The common pathway begins where the pathways come together, which leads to formation of a mesh-like structure, the beginning of a clot, which is then strengthened to form the final solid clot that stops the bleeding.
What are clotting factors?
Clotting factors are special proteins in your blood, numbered from 1 to 13, or commonly written in Roman numerals as I to XIII. As mentioned, clotting factors interact with each other along with other proteins to drive the clotting cascade.
If one factor is missing or doesn't work properly, it can affect the entire process, leading to clotting disorders such as hemophilia A or B (in which your blood struggles to clot properly) or thrombosis (in which your blood clots too easily, even when it shouldn’t).
Hemophilia and clotting factors
Hemophilia is a lifelong inherited bleeding disorder where blood doesn’t clot normally. Hemophilia occurs because the body has low levels of specific clotting factors, which are essential proteins that help the blood form clots and stop bleeding.
People living with hemophilia may experience prolonged bleeding and, in some cases, spontaneous bleeding into joints and muscles, even without an injury. To help manage bleeding and support clotting, treatment options may include clotting factor concentrates (CFCs) or nonfactor treatments.
Treating hemophilia with CFCs
If your body doesn't make enough clotting factors, you may need hemophilia clotting factor drugs, often called CFCs. These are medicines that replace the missing factors. Sometimes, the body can develop "inhibitors" that block CFCs from working properly.
What clotting factor deficiencies cause hemophilia?
Hemophilia A is caused by a deficiency in Factor VIII, whereas hemophilia B is caused by a deficiency in Factor IX.
The severity of hemophilia is determined by the amount of clotting factor in the blood. For example, people living with severe hemophilia A produce less than 1% of the normal amount of clotting factor.
Why are Factor VIII and Factor IX so important?
Factor VIII and Factor IX are important proteins that help your blood clot and stop bleeding.
Factor VIII works with Factor IX to produce more of a key protein called thrombin, which helps form a strong, stable clot. If either factor is missing or not working properly, blood takes longer to clot, leading to excessive bleeding.
Where are Factor VIII and Factor IX produced?
Factor VIII is mainly produced by specialized cells in the lining of blood vessels, particularly in the liver. Other areas include the kidneys and spleen.
Factor IX is made only in the liver, where it relies on vitamin K to be produced properly.
How are Factor VIII and Factor IX produced?
Your body has genes that act like instruction manuals for making important proteins. The Factor VIII and Factor IX genes, found on the X chromosome, provide the instructions for making Factor VIII and Factor IX. Once made, these factors enter the bloodstream, ready to act when needed.
It is not known if Qfitlia is safe and effective in children younger than 12 years of age.
Qfitlia can cause SERIOUS SIDE EFFECTS, including:
Abnormal blood clotting (thrombotic events): Serious blood clots have occurred in people treated with Qfitlia. Qfitlia can cause blood clots to form in the blood vessels in your arms, legs, lungs, heart, brain, eyes, or head. Your risk of blood clots is greater if your antithrombin (AT) blood level is persistently less than 15% or if you have certain other conditions. Your healthcare provider (HCP) will check your AT blood levels before and during treatment with Qfitlia
Gallbladder disease: Qfitlia can cause gallstones and inflammation of your gallbladder, which might require surgery to remove your gallbladder. Tell your HCP right away if you develop stomach pain, indigestion, nausea, or vomiting. Your HCP may temporarily or permanently stop Qfitlia if you develop any of these symptoms
What is the most important information I should know about Qfitlia?
Qfitlia helps your blood form clots. Do not stop using Qfitlia without talking to your HCP. If you miss doses or stop using Qfitlia, you may no longer be protected against bleeding.
Use of a clotting factor concentrate (CFC) or bypassing agent (BPA) to help protect against bleeding must be stopped within 7 days after your first dose of Qfitlia.
Your HCP may prescribe on-demand CFC or BPA if you bleed during treatment with Qfitlia. Carefully follow your HCP’s instructions regarding when to use on-demand treatment with CFC or BPA, including the prescribed dose and timing of the CFC or BPA.
Get medical help right away if you get any of these signs or symptoms of blood clots during or after treatment with Qfitlia:
- Swelling, pain, or redness in arms or legs
- Coughing up blood
- Shortness of breath
- Severe chest pain or tightness of the chest
- Fast heart rate
- Feeling faint or passing out
- Severe or persistent headache
- Difficulty speaking or understanding language
- Feeling confused
- Numbness or weakness in your face, arms, or legs
- Sudden loss or changes in your vision, eye pain, or swelling
What are the possible side effects of Qfitlia?
Qfitlia can cause other serious side effects, including an increase in your blood liver enzymes. Your HCP will do blood tests to check your liver function before and during treatment with Qfitlia
The most common side effects of Qfitlia include viral infection, common cold symptoms, and bacterial infection
These are not all the possible side effects of Qfitlia.
What should I tell my HCP before using Qfitlia?
Tell your HCP about all of your medical conditions, including if you have liver problems, a history of gallbladder disease, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed
Females who are able to become pregnant: Hormonal birth control may increase your risk of blood clots if used during treatment with Qfitlia. Talk to your HCP about effective forms of non-hormonal birth control you can use before starting and during treatment with Qfitlia
Tell your HCP about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements
